Internet-Based Cognitive Behavioral Therapy for Depressive Symptoms in Adolescents With Type 1 Diabetes Mellitus

Sponsor
University of Texas Southwestern Medical Center (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT03655067
Collaborator
University of Illinois at Chicago (Other)
60
1
2
17.5
3.4

Study Details

Study Description

Brief Summary

This study evaluates the use of an established internet-based cognitive behavioral therapy intervention in a group of adolescents with type 1 diabetes and mild to moderate depressive symptoms. Half of the participants will receive the internet-based intervention while the other half will receive usual care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CATCH-IT
N/A

Detailed Description

Adolescents with diabetes have a higher incidence of subclinical and clinical depression compared to healthy adolescents. Patients with diabetes who are clinically or subclinically depressed are at high risk for poor glycemic control.

Studies evaluating prevention and treatment strategies for depression in patients with type 1 diabetes have shown that group cognitive-behavioral therapy (CBT) and individual interpersonal psychotherapy (IPT) can reduce the risk of depressive illness in adolescents with diabetes. Computerized interventions show evidence of being efficacious, and have been recommended as the "first line" intervention.

The Competent Adulthood Transition with Cognitive Humanistic and Interpersonal Teaching (CATCH-IT) internet program has shown positive results with adolescents at risk for depression, but has not been used in patients with a chronic illness like diabetes. CATCH-IT is based on established CBT and IPT treatment models. It includes a) an innovative and effective brief practitioner-provided motivation enhancement component (in person at enrollment and through phone calls) and b) self-directed modules for the adolescent that can be accessed on the internet.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomized at the baseline visit to the CATCH-IT Intervention or Control groupParticipants will be randomized at the baseline visit to the CATCH-IT Intervention or Control group
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Use of an Internet-Based Cognitive Behavioral Therapy Intervention (CATCH-IT) for the Treatment of Depressive Symptoms in Adolescents With Type 1 Diabetes Mellitus
Actual Study Start Date :
Dec 15, 2020
Actual Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

The participants in the Intervention group will receive the CATCH-IT program which consists of a motivational component and the internet program for the adolescent. The participants in the Intervention group will receive motivational interviewing at their baseline visit as well as motivational coaching with safety phone calls during weeks 1-6.

Behavioral: CATCH-IT
The CATCH-IT internet program consists of 14 modules and exercises and activities based on best practices components of depression prevention. They will be instructed to complete at least 2 modules a week, over a period of 6 weeks. This would require at least 40 minutes per week (approximately 20 minutes minimum per module).

No Intervention: Usual Care

Participants in the Usual Care group may undergo an evaluation with the Social Worker if the clinician determines that it is necessary. The participants in the Usual Care group will also receive motivational coaching with safety phone calls during weeks 1-6.

Outcome Measures

Primary Outcome Measures

  1. Center for Epidemiological Studies - Depression Scale (CES-D) [6 weeks]

    A screening test for depression and depressive disorder. The CESD measures symptoms defined by the American Psychiatric Association' Diagnostic and Statistical Manual (DSM-V) for a major depressive episode.

Secondary Outcome Measures

  1. Hemoglobin A1c [12 weeks]

    Hemoglobin A1c- a 3-month surrogate marker of diabetes control

  2. Patient Health Questionnaire Modified for Teens [6 weeks and 12 weeks]

    A self-completion screening questionnaire designed to detect symptoms of depression and suicide risk in adolescents.

  3. Problem Areas in Diabetes - Teen version [6 weeks and 12 weeks]

    A validated measure of diabetes distress designed specifically for adolescents with type 1 diabetes

Eligibility Criteria

Criteria

Ages Eligible for Study:
13 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 13-17 receiving ongoing medical care in the Diabetes Clinic at Children's Medical Center Dallas.

  • Patients must be fluent in English (the materials on the site have not been validated in any other language), be in at least the 8th grade, report/demonstrate comfort with use of a computer, and regular, convenient and discreet access to the internet.

  • Patients must experience at least sub-threshold depression (CES-D score > 15).

  • Patients must have had the diagnosis of type 1 diabetes for at least 12 months.

Exclusion Criteria:
  • Patients who are medically unstable during their diabetes clinic visit will be excluded (i.e. diabetes ketoacidosis, symptomatic hypoglycemia).

  • Patients who are too severely depressed for this form of intervention (i.e. meet criteria for MDD, endorse suicidal intent, PHQ-A score ≥ 20), those with a diagnosis or symptoms of severe mental illness (schizophrenia, bipolar disorder), prior psychiatric hospitalization, prior self-harm attempt.

  • Patients receiving ongoing counseling or therapy services within the last year, by a licensed professional (counselor, psychologist or psychiatrist).

  • Patients who are currently taking or begin taking psychotropic medications during study participation will be excluded/withdrawn.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Medical Center Dallas Texas United States 75235

Sponsors and Collaborators

  • University of Texas Southwestern Medical Center
  • University of Illinois at Chicago

Investigators

  • Principal Investigator: Olga T Gupta, MD, UTSW

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Olga Gupta, Assistant Professor, University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT03655067
Other Study ID Numbers:
  • STU-2020-0230
First Posted:
Aug 31, 2018
Last Update Posted:
Jan 24, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 24, 2022